• 1
    Centers for Disease Control and Prevention: annual smoking-attributable mortality, years of potential life lost, and economic costs—United States 1995–1999. MMWR Morb Mortal Wkly Rep. 2004; 51: 300303.
  • 2
    Fiore M,Bailey WC,Cohen SJ. Treating tobacco use and dependence. Clinical Practice Guideline. Rockville, MD: U.S. Department of Health and Human Services; 2000.
  • 3
    Ries LAG,Eisner MP,Kosary CL, et al. Cancer statistics review, 1973–1999. Bethesda, MD: National Cancer Institute; 2002.
  • 4
    Allen JA,Vallone D,Haviland ML, et al. Tobacco use among middle and high school students. MMWR Morb Mortal Wkly Rep. 2003; 52: 10961098.
  • 5
    Mulhern RK,Tyc VL,Phipps S, et al. Health-related behaviors of survivors of childhood cancer. Med Pediatr Oncol. 1995; 25: 159165.
  • 6
    Tyc VL,Lensing S,Klosky J,Rai SN. A comparison of tobacco-related risk factors between adolescents with and without cancer. J Pediatr Psychol. 2004; 30: 359370.
  • 7
    Hollen PJ,Hobbie WL,Finley SM. Testing the effects of a decision-making and risk-reduction program for cancer-surviving adolescents. Oncol Nurs Forum. 1999; 26: 14751486.
  • 8
    U.S. Department of Health and Human Services. Preventing tobacco use among young people: a report of the Surgeon General. Atlanta, GA: U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 1994.
  • 9
    Arday DR,Giovino GA,Schulman J,Nelson DE,Mowery P,Samet JM. Cigarette smoking and self-reported health problems among US high school seniors, 1982–1989. Am J Health Promot. 1995; 10: 111116.
  • 10
    Hak DJ,Lee SS,Goulet JA. Success of exchange reamed intramedullary nailing for femoral shaft nonunion or delayed union. J Orthop Trauma. 2000; 14: 178182.
  • 11
    Children's Ocology Group. Long-term follow-up guidelines for survivors of childhood, adolescent, and young adult cancers. Available at URL: Accessed on February 2, 2007.
  • 12
    O'Driscoll BR,Hasleton PS,Taylor PM,Poulter LW,Gattamaneni HR,Woodcock AH. Active lung fibrosis up to 17 years after chemotherapy with carmustine (BCNU) in childhood. N Engl J Med. 1990; 323: 378382.
  • 13
    Benoist MR,Lemerle J,Jean R. Effects on pulmonary function of whole lung irradiation for Wilm's tumor in children. Thorax. 1982; 37: 175180.
  • 14
    Lipshultz SE,Colan SD,Gelbar RD,Perez-Atayde AR,Sallan SE,Sanders SP. Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood. N Engl J Med. 1991; 324: 808815.
  • 15
    Kaste SC,Rai SN,Fleming K, et al. Changes in bone mineral density in survivors of childhood acute lymphoblastic leukemia. Pediatr Blood Cancer. 2006; 46: 7787.
  • 16
    Tyc VL,Hadley W,Crockett G. Brief report: predictors of intentions to use tobacco among adolescent survivors of cancer. J Pediatr Psychol. 2001; 26: 117121.
  • 17
    Robinson LA,Klesges RC,Zbikowski SM,Glaser R. Predictors of risk for different stages of adolescent smoking in a biracial sample. J Consult Clin Psychol. 1997; 65: 653662.
  • 18
    Lerman C,Audrain J,Main D, et al. Evidence suggesting the role of specific genetic factors in cigarette smoking. Health Psychol. 1999; 18: 1420.
  • 19
    Comings D,Ferry L,Bradshaw-Robinson S,Burchette R,Chiu C,Muhleman D. The dopamine D2 receptor (DRD2) gene: a genetic risk factor in smoking. Pharmacogenetics. 1996; 6: 7379.
  • 20
    Spitz M,Shi H,Yang F,Hudmon K,Jiang H,Chamberlain R. Case-control study of the D2 dopamine receptor gene and smoking status in lung cancer patients. J Natl Cancer Inst. 1998; 90: 358363.
  • 21
    Tercyak KP,Nicolas M,Councill T,Prahlad S,Taylor KL,Shad AT. Brief report: health beliefs among survivors of childhood cancer. J Pediatr Psychol. 2004; 29: 397402.
  • 22
    Audrain-McGovern J,Lerman C,Wileyto EP,Rodgigues D,Shields PG. Interacting effects of genetic predisposition and depression on adolescent smoking progression. Am J Psychiatry. 2004; 161: 12241230.
  • 23
    Leventhal H,Cleary PD. The smoking problem: a review of the research and theory in behavioral risk modification. Psychol Bull. 1980; 88: 370405.
  • 24
    Hobbie WL,Stuber M,Meeske K, et al. Symptoms of posttraumatic stress in young adult survivors of childhood cancer. J Clin Oncol. 2000; 18: 40604066.
  • 25
    Upadhyaya HP,Rose K,Wang W, et al. Attention-deficit/hyperactivity disorder, medication treatment, and substance use patterns among adolescents and young adults. J Child Adolesc Psychopharmacol. 2005; 15: 799809.
  • 26
    Reddick WE,Shan ZY,Glass JO, et al. Smaller white-matter volumes are associated with larger deficits in attention and learning among long-term survivors of acute lymphoblastic leukemia. Cancer. 2006; 106: 941949.
  • 27
    Reeves CB,Palmer SL,Reddick WE, et al. Attention and memory functioning among pediatric patients with medulloblastoma. J Pediatr Psychol. 2006; 31: 272280.
  • 28
    Schum LN,Robinson LA,Tyc VL,Hinds PS,Hudson MM,Robison LL. Attention problems as a risk factor for smoking among survivors of childhood cancer. Poster presented at Psychosocial and Neurocognitive Consequences of Childhood Cancer: A Symposium in Tribute to Raymond K. Mulhern;Memphis, TN. September 13–15, 2006.
  • 29
    Hudson MM,Tyc VL,Srivastava DK, et al. Multi-component behavioral interventions to promote health protective behaviors in childhood cancer survivors: the Protect Study. Med Pediatr Oncol.2002; 39: 211.
  • 30
    Cox CL,McLaughlin RA,Rai SN,Steen BD,Hudson MM. Adolescent survivors: a secondary analysis of a clinical trial targeting behavior change. Pediatr Blood Cancer. 2005; 45: 144154.
  • 31
    Tyc VL,Rai S,Lensing S,Klosky J,Stewart D,Gattuso J. Intervention to reduce intentions to use tobacco among pediatric cancer survivors. J Clin Oncol. 2003; 21: 13661372.
  • 32
    Fiore MC,Bailey WC,Cohen SJ, et al. Treating tobacco use and dependence. Quick reference guide for clinicians. Rockville, MD: U.S. Department of Health and Human Services, Public Health Service; 2000.
  • 33
    Smith T,House R,Crogham I, et al. Nicotine patch therapy in adolescent smokers. Pediatrics. 1996; 98: 659667.
  • 34
    Hurt R,Croghan G,Beede S,Wolter T,Croghan I,Patten C. Nicotine patch therapy in 101 adolescent smokers. Arch Pediatr Adolesc Med. 2000; 154: 3137.
  • 35
    Hanson K,Allen S,Hatsukami D. Treatment of adolescent smokers with the nicotine patch. Nicotine Tob Res. 2003; 5: 515526.
  • 36
    Moolchan E,Robinson M,Ernst M, et al. Safety and efficacy of the nicotine patch and gum for the treatment of adolescent tobacco addiction. Pediatrics. 2005; 115: 407414.
  • 37
    Fiore M,Bailey WC,Cohen SJ, et al. Treating tobacco use and dependence. In: Clinical Practice Guideline. Rockville, MD: U.S. Department of Health and Human Services; 2000.
  • 38
    Upadhyaya HP,Brady KT,Wang W. Bupropion SR in adolescents with comorbid ADHD and nicotine dependence: a pilot study. J Am Acad Child Adolesc Psychiatry. 2004; 43: 199205.
  • 39
    Killen JD,Robinson TN,Ammerman S, et al. Randomized clinical trial of the efficacy of bupropion combined with nicotine patch in the treatment of adolescent smokers. J Consult Clin Psychol. 2004; 72: 729735.
  • 40
    Zyban. Prescribing information. Available at URL: Accessed on February 1, 2007.
  • 41
    Weinstein ND. Testing 4 competing theories of health-protective behavior. Health Psychol. 1993; 12: 324333.
  • 42
    Kann L,Brener ND,Warren CW,Collins JL,Giovino GA. An assessment of the effect of data collection setting on the prevalence of health risk behaviors among adolescents. J Adolesc Health. 2002; 31: 327335.
  • 43
    Samant R,Tucker T. Analysis of cigarette smoking habits of cancer patients referred to the Northeastern Ontario Regional Cancer Centre. J Cancer Educ. 2003; 18: 157160.
  • 44
    Yu GP,Ostroff JS,Zhang ZF,Tang J,Schantz SP. Smoking history and cancer patient survival: a hospital cancer registry study. Cancer Detect Prev. 1997; 21: 497509.
  • 45
    Emmons K,Li FP,Whitton J, et al. Predictors of smoking initiation and cessation among childhood cancer survivors: a report from the Childhood Cancer Survivor Study. J Clin Oncol. 2002; 20: 16081616.
  • 46
    Des Rochers C,Dische S,Sanders MI. The problem of cigarette smoking in radiotherapy for cancer in the head and neck. Clin Oncol. 1992; 4: 214216.
  • 47
    Cinciripini PM,Gritz ER,Tsoh, JY,Skaar KL. Smoking cessation and cancer prevention. In: HollandJC, editor. Psycho-Oncology. New York: Oxford University Press; 1998.
  • 48
    Goodman MT,Kolonel LN,Wilkens LR,Yoshizawa CN,Le Marchand L. Smoking history and survival among lung cancer patients. Cancer Causes Control. 2005; 1: 155163.
  • 49
    Day GL,Blot WJ,Shore RE, et al. Second cancers following oral and pharyngeal cancers: role of tobacco and alcohol. J Natl Cancer Inst. 1994; 86: 131137.
  • 50
    Goodwin SJ,McCarthy CM,Pusic AL, et al. Complications in smokers after postmastectomy tissue expander/implant breast reconstruction. Ann Plast Surg. 2005; 55: 1619.
  • 51
    Boivin J. Smoking, treatment for Hodgkin's disease, and subsequent lung cancer risk. J Natl Cancer Inst. 1995; 87: 15021503.
  • 52
    Muller J. Disturbance of pubertal development after cancer treatment. Best Pract Res Clin Endocrinol Metab. 2002; 16: 91103.
  • 53
    Heyn R,Raney B,Hays D, et al. Late effects of therapy in patients with paratesticular rhabdomyosarcoma. J Clin Oncol. 1992; 10: 614623.
  • 54
    Kersun L,Wimmer R,Hoot A,Meadows A. Secondary malignant neoplasms of the bladderafter cyclophosphamide treatment of childhood acute lymphocytic leukemia. Pediatric Blood Cancer. 2004; 42: 289291.
  • 55
    Ebbert JO,Williams BA,Sun Z, et al. Duration of smoking abstinence as a predictor for non small lung cancer survival in women. Lung Cancer. 2005; 47: 165172.
  • 56
    Okubo K,Mark EJ,Flieder D, et al. Bronchoalveolar carcinoma: clinical, radiologic, and pathologic factors and survival. J Thorac Cardiovasc Surg. 1999; 118: 702709.
  • 57
    Sanderson Cox L,Sloan JA,Patten CA, et al. Smoking behavior of 226 patients with diagnosis of stage IIIA/IIIB non-small cell lung cancer. Psychooncology. 2002; 11: 472478.
  • 58
    Jensen K,Jensen AB,Grau C. Smoking has a negative impact upon health related quality of life after treatment for head and neck cancer. Oral Oncol. 2007; 43: 187192.
  • 59
    Humphris GM,Rogers SN. The association of cigarette smoking and anxiety, depression and fears of recurrence in patients following treatment of oral and oropharyngeal malignancy. Eur J Cancer Care. 2004; 13: 328335.
  • 60
    Emmons K,Butterfield R,Puleo E, et al. Smoking among participants in the childhood cancer survivors cohort: the partnership for health study. J Clin Oncol. 2003; 21: 189196.
  • 61
    Schnoll RA,Malstrom M,James C, et al. Correlates of tobacco use among smokers and recent quitters diagnosed with cancer. Patient Educ Couns. 2002; 46: 137145.
  • 62
    Schnoll RA,Engstrom PF,Subramanian S,Demidov L,Wielt DB,Tighiouart M. Prevalence and correlates of tobacco use among Russian cancer patients: implications for the development of smoking cessation interventions at a cancer center in Russia. Int J Behav Med. 2006; 13: 1625.
  • 63
    Ostroff J,Garland J,Moadel A, et al. Cigarette smoking patterns in patients after treatment of bladder cancer. J Cancer Educ. 2000; 15: 8690.
  • 64
    Schnoll RA,James C,Malstrom M, et al. Longitudinal predictors of continued tobacco use among patients diagnosed with cancer. Ann Behav Med. 2003; 25: 214221.
  • 65
    Lambert MT,Terrell JE,Copeland LA,Ronis DL,Duffy SA. Cigarettes, alcohol, and depression: characterizing head and neck cancer survivors in 2 systems of care. Nicotine Tob Res. 2005; 7: 233241.
  • 66
    Ark WV,DiNardo LJ,Oliver DS. Factors affecting smoking cessation in patients with head and neck cancer. Laryngoscope. 1997; 107: 888892.
  • 67
    Gritz ER,Carr CR,Rapkin D, et al. Predictors of long-term smoking cessation in head and neck cancer patients. Cancer Epidemiol Biomarkers Prev. 1993; 2: 261270.
  • 68
    Cox LS,Patten CA,Ebbert JO, et al. Tobacco use outcomes among patients with lung cancer treated for nicotine dependence. J Clin Oncol. 20: 34613469, 2002.
  • 69
    Chan Y,Irish JC,Wood SJ, et al. Smoking cessation in patients diagnosed with head and neck cancer. J Otolaryngol. 2004; 33: 7581.
  • 70
    Hatsukami DK,Rennard S,Jorenby D, et al. Safety and immunogenicity of a nicotine conjugate vaccine in current smokers. Clin Pharmacol Ther. 2005; 78: 456467.
  • 71
    Cornuz J,Klinger K,Mueller P, et al. A therapeutic vaccine for nicotine dependence: results of a phase I and a randomized phase II study. Presented at: American Society of Clinical Oncology, Orlando, Florida, May 13–17, 2005.
  • 72
    Cahill K,Stead LF,Lancaster T. Nicotine receptor partial agonists for smoking cessation. Cochrane Database Syst Rev 2007; 1: CD006103.
  • 73
    Gonzales D,Rennard SI,Nides M, et al. Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial. JAMA. 2006; 296: 4755.
  • 74
    Nides M,Oncken C,Gonzales D, et al. Smoking cessation with varenicline, a selective alpha4beta2 nicotinic receptor partial agonist: results from a 7-week, randomized, placebo- and bupropion-controlled trial with 1-year follow-up. Arch Intern Med. 2006; 166: 15611568.
  • 75
    Jorenby DE,Hays JT,Rigotti NA, et al. Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial. JAMA. 2006; 296: 5663.
  • 76
    Pfizer Laboratories. Chantix (varenicline) tablets prescribing information. New York: Pfizer; 2006.
  • 77
    Pfizer for Professionals. Chantix tablets: indications and usage. Available at URL: info/chantix_pi_indications_and_usage.jsp Accessed February 10, 2007.
  • 78
    Griebel B,Wewers ME,Baker CA. The effectiveness of a nurse-managed minimal smoking-cessation intervention among hospitalized patients with cancer. Oncol Nurs Forum. 1998; 25: 897902.
  • 79
    Schnoll RA,Zhang B,Montsettar R, et al. Brief physician-initiated quit smoking strategies for clinical oncology settings: a trial coordinated by the Eastern Cooperative Oncology Group. J Clin Oncol. 2003; 21: 355365.
  • 80
    Duffy SA,Ronis DL,Valenstein M, et al. A tailored smoking, alcohol, and depression intervention for head and neck cancer patients. Cancer Epidemiol Biomarkers Prev. 2006; 15: 22032208.
  • 81
    Emmons KM,Puleo E,Park E, et al. Peer-delivered smoking counseling for childhood cancer survivors increases rate of cessation: the partnership for health study. J Clin Oncol. 2005; 23: 65166523.
  • 82
    Park ER,Puleo E,Butterfield RM, et al. A process evaluation of a telephone-based peer-delivered smoking cessation intervention for adult survivors of childhood cancer: the partnership for health study. Prev Med. 2006; 42: 435442.
  • 83
    Garces YI,Schroeder DR,Nirelli LM, et al. Tobacco use outcomes among patients with head and neck carcinoma treated for nicotine dependence: a matched-pair analysis. Cancer. 2004; 101: 116124.
  • 84
    Tyas SL,Pederson LL. Psychosocial factors related to adolescent smoking: a critical review of the literature. Tob Control. 1998; 7: 409420.
  • 85
    Katz DA,Muehlenbruch DR,Brown RB,Fiore MC,Baker TB, for the AHRQ Smoking Cessation Guideline Study Group. Effectiveness of a clinic-based strategy for implementing the AHRQ smoking cessation guideline in primary care. Prev Med. 2002; 35: 293301.
  • 86
    Mackie E,Hill J,Kondryn H,McNally R. Adult psychosocial outcomes in long-term survivors of acute lymphoblastic leukaemia and Wilms' tumour: a controlled study. Lancet. 2000; 355: 13101314.
  • 87
    Fiore MC,Bailey WC,Cohen, SF. Smoking cessation. Clinical Practice Guideline No. 18. Washington, DC: Department of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research, and Centers for Disease Control; 1996.
  • 88
    Frankowski BL,Weaver SO,Secker-Walker RH. Advising parents to stop smoking: pediatricians' and parents' attitudes. Pediatrics. 1993; 91: 296300.